Structure-activity investigations of Santacruzamate A, a potent histone deacetylase inhibitor isolated from a Panamanian cyanobacterium

被引：0
|
作者：
Pavlik, C. M. [1 ]
Balunas, M. J. [1 ]
机构：
[1] Univ Connecticut, Dept Pharmaceut Sci, Div Med Chem, Storrs, CT 06269 USA
来源：
PLANTA MEDICA | 2012年 / 78卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q94 [植物学];
学科分类号：
071001 ;
摘要：
引用
收藏
页码：1077 / 1078
页数：2
相关论文
共 50 条
  • [1] Santacruzamate A, a Potent and Selective Histone Deacetylase Inhibitor from the Panamanian Marine Cyanobacterium cf. Symploca sp.
    Pavlik, Christopher M.
    Wong, Christina Y. B.
    Ononye, Sophia
    Lopez, Dioxelis D.
    Engene, Niclas
    McPhail, Kerry L.
    Gerwick, William H.
    Balunas, Marcy J.
    JOURNAL OF NATURAL PRODUCTS, 2013, 76 (11): : 2026 - 2033
  • [2] Discovery and development of Santacruzamate A, a potent and selective histone deacetylase inhibitor
    Balunas, M. J.
    Pavlik, C. M.
    Wong, C. Y. B.
    Lopez, D. D.
    Engene, N.
    McPhail, K.
    Gerwick, W. H.
    PLANTA MEDICA, 2012, 78 (11) : 1050 - 1050
  • [3] Structure-activity relationship study on histone deacetylase (HDAC) inhibitors derived from Santacruzamate
    Hogle, Emily
    Onate, Alma
    Tucker, Janelle
    Leduc, Rachel
    Thuy Do
    Klein, Reid
    Thowfeik, Fathima
    Merino, Edward
    Ma, Lili
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [4] Structure-activity relationships of aryloxyalkanoic acid hydroxyamides as potent inhibitors of histone deacetylase
    Marson, Charles M.
    Mahadevan, Thevaki
    Dines, Jon
    Sengmany, Stphane
    Morrell, James M.
    Alao, John P.
    Joel, Simon P.
    Vigushin, David M.
    Coombes, R. Charles
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (01) : 136 - 141
  • [5] Potent antimalarial activity of histone deacetylase inhibitor analogues
    Andrews, K. T.
    Tran, T. N.
    Lucke, A. J.
    Kahnberg, P.
    Le, G. T.
    Boyle, G. M.
    Gardiner, D. L.
    Skinner-Adams, T. S.
    Fairlie, D. P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (04) : 1454 - 1461
  • [6] Quantitative structure-activity relationship study of histone deacetylase inhibitors
    Xie, AH
    Liao, CZ
    Li, BY
    Li, ZB
    Ning, ZQ
    Hu, WM
    Lu, XP
    Zhou, JJ
    Shi, LM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U555 - U555
  • [7] A structure-activity relationship survey of histone deacetylase (HDAC) inhibitors
    Bozorgi, Atefeh Hajiagha
    Bagheri, Mehdi
    Aslebagh, Roshanak
    Rajabi, Mansoureh Sadat
    CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 2013, 125 : 132 - 138
  • [8] Investigations into the structure-activity relationship of fostriecin, a potent inhibitor of Ser/Thr protein phosphatases
    Amable, L
    Moring, KL
    Swingle, MR
    Ratti, P
    Buck, S
    Boger, DL
    Honkanen, R
    FASEB JOURNAL, 2006, 20 (05): : A924 - A924
  • [9] Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo
    Vigushin, DM
    Ali, S
    Pace, PE
    Mirsaidi, N
    Ito, K
    Adcock, I
    Coombes, RC
    CLINICAL CANCER RESEARCH, 2001, 7 (04) : 971 - 976
  • [10] A novel histone deacetylase inhibitor with potent antiproliferative activity in ovarian cancer cells.
    Mand, Michael
    Edwards, Ceazon
    Tumati, Vasu
    Kulp, Samuel K.
    Chen, Ching-Shih
    Nephew, Kenneth P.
    Balch, Curtis
    CANCER RESEARCH, 2006, 66 (08)
12345